Liu Z - Search Results

1

The Upregulation of PI3K/Akt and MAP Kinase Pathways is Associated with Resistance of Microtubule-Targeting Drugs in Prostate Cancer.

Liu Z, Zhu G, Getzenberg RH, Veltri RW. Liu Z, et al. J Cell Biochem. 2015 Jul;116(7):1341-9. doi: 10.1002/jcb.25091. J Cell Biochem. 2015. PMID: 25640606

2

Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation.

Terada N, Shiraishi T, Zeng Y, Aw-Yong KM, Mooney SM, Liu Z, Takahashi S, Luo J, Lupold SE, Kulkarni P, Getzenberg RH. Terada N, et al. Among authors: liu z. J Cell Biochem. 2014 Sep;115(9):1505-15. doi: 10.1002/jcb.24805. J Cell Biochem. 2014. PMID: 24604720 Free PMC article.

3

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.

Zhu G, Liu Z, Epstein JI, Davis C, Christudass CS, Carter HB, Landis P, Zhang H, Chung JY, Hewitt SM, Miller MC, Veltri RW. Zhu G, et al. Among authors: liu z. Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1864-72. doi: 10.1158/1055-9965.EPI-15-0496. Epub 2015 Sep 24. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26404961 Free PMC article.

4

Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin.

Liu D, Hou P, Liu Z, Wu G, Xing M. Liu D, et al. Among authors: liu z. Cancer Res. 2009 Sep 15;69(18):7311-9. doi: 10.1158/0008-5472.CAN-09-1077. Epub 2009 Aug 25. Cancer Res. 2009. PMID: 19706758 Free PMC article.

5

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.

Liu Z, Hou P, Ji M, Guan H, Studeman K, Jensen K, Vasko V, El-Naggar AK, Xing M. Liu Z, et al. J Clin Endocrinol Metab. 2008 Aug;93(8):3106-16. doi: 10.1210/jc.2008-0273. Epub 2008 May 20. J Clin Endocrinol Metab. 2008. PMID: 18492751

6

Induction of sodium/iodide symporter (NIS) expression and radioiodine uptake in non-thyroid cancer cells.

Liu Z, Xing M. Liu Z, et al. PLoS One. 2012;7(2):e31729. doi: 10.1371/journal.pone.0031729. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359623 Free PMC article.

7

Inhibitory effects of the mitogen-activated protein kinase kinase inhibitor CI-1040 on the proliferation and tumor growth of thyroid cancer cells with BRAF or RAS mutations.

Liu D, Liu Z, Jiang D, Dackiw AP, Xing M. Liu D, et al. Among authors: liu z. J Clin Endocrinol Metab. 2007 Dec;92(12):4686-95. doi: 10.1210/jc.2007-0097. Epub 2007 Oct 2. J Clin Endocrinol Metab. 2007. PMID: 17911174

8

IQGAP1 plays an important role in the invasiveness of thyroid cancer.

Liu Z, Liu D, Bojdani E, El-Naggar AK, Vasko V, Xing M. Liu Z, et al. Among authors: liu d. Clin Cancer Res. 2010 Dec 15;16(24):6009-18. doi: 10.1158/1078-0432.CCR-10-1627. Epub 2010 Oct 19. Clin Cancer Res. 2010. PMID: 20959410 Free PMC article.

9

Hypermethylation of the DNA mismatch repair gene hMLH1 and its association with lymph node metastasis and T1799A BRAF mutation in patients with papillary thyroid cancer.

Guan H, Ji M, Hou P, Liu Z, Wang C, Shan Z, Teng W, Xing M. Guan H, et al. Among authors: liu z. Cancer. 2008 Jul 15;113(2):247-55. doi: 10.1002/cncr.23548. Cancer. 2008. PMID: 18470905 Free article.

10

Induction of thyroid gene expression and radioiodine uptake in melanoma cells: novel therapeutic implications.

Hou P, Liu D, Ji M, Liu Z, Engles JM, Wahl RL, Xing M. Hou P, et al. Among authors: liu z, liu d. PLoS One. 2009 Jul 10;4(7):e6200. doi: 10.1371/journal.pone.0006200. PLoS One. 2009. PMID: 19593429 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

83,229 results

Search Page